Modulation of Multidrug Resistance by SDZ PSC 833 in Leukemic and Solid‐tumor‐bearing Mouse Models

P‐Glycoprotein inhibitors, including the nonimmunosuppressive cyclosporin D analog SDZ PSC 833 (PSC 833), have been developed to circumvent multidrug resistance. In the present study, the potential of PSC 833 in reversing multidrug resistance was evaluated in various systemic treatment models with l...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Toru, Naito, Mikihiko, Oh‐hara, Tomoko, Itoh, Yohjiro, Cohen, Dalia, Tsuruo, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1996
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921055/
https://www.ncbi.nlm.nih.gov/pubmed/8609068
http://dx.doi.org/10.1111/j.1349-7006.1996.tb03157.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921055/
https://www.ncbi.nlm.nih.gov/pubmed/8609068
http://dx.doi.org/10.1111/j.1349-7006.1996.tb03157.x

Ejemplares similares